abstract |
The present invention relates to a compound of formula I n n n n n n n n n n wherein R 1 , R 2 , R 3 , R 4 , R 7 , m and n are as defined herein. n These compounds are high potential NK-3 receptor antagonists useful for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD). |